Citadel Advisors
STTK icon

Citadel Advisors’s Shattuck Labs STTK Stock Holding History

Citadel Advisors’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$952K Buy
148,021
+79,175
+115% +$376K ﹤0.01% 7770
2025
Q4 		$251K Buy
+68,846
New +$164K ﹤0.01% 10540
2024
Q4 		– Sell
-175,342
Closed -$612K – 15359
2024
Q3 		$612K Sell
175,342
-19,753
-10% -$73.6K ﹤0.01% 7829
2024
Q2 		$753K Buy
195,095
+191,851
+5,914% +$1.56M ﹤0.01% 7190
2024
Q1 		$29K Buy
+3,244
New +$29.7K ﹤0.01% 12720
2023
Q4 		– Sell
-52,887
Closed -$144K – 15218
2023
Q3 		$80.4K Sell
52,887
-19,116
-27% -$43.6K ﹤0.01% 11173
2023
Q2 		$225K Sell
72,003
-2,401
-3% -$6.97K ﹤0.01% 9631
2023
Q1 		$219K Buy
74,404
+4,405
+6% +$15.6K ﹤0.01% 10019
2022
Q4 		$161K Sell
69,999
-51,962
-43% -$130K ﹤0.01% 10499
2022
Q3 		$329K Sell
121,961
-51,795
-30% -$194K ﹤0.01% 9361
2022
Q2 		$705K Sell
173,756
-120,488
-41% -$436K ﹤0.01% 7855
2022
Q1 		$1.25M Buy
294,244
+115,726
+65% +$656K ﹤0.01% 7189
2021
Q4 		$1.52M Buy
178,518
+152,785
+594% +$2.1M ﹤0.01% 6860
2021
Q3 		$524K Buy
+25,733
New +$551K ﹤0.01% 9753

Other funds holding STTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CEI
Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Citadel Advisors's STTK Position: Q1 2026 in Review

Citadel Advisors increased its Shattuck Labs (STTK) stake by 115% in Q1 2026, buying an estimated $376K and bringing the position to 148,021 shares worth $952K. The position accounts for ﹤0.01% of the portfolio, ranked #7770.

Citadel Advisors first reported a position in STTK in Q3 2021 and has held it in 14 quarters since. The position peaked at $1.52M in Q4 2021. 84 funds tracked by Wall St. Rank hold STTK as of Q1 2026.

  • Citadel Advisors held 148,021 shares of Shattuck Labs worth $952K as of Q1 2026.
  • Citadel Advisors bought 79,175 Shattuck Labs shares in Q1 2026, an estimated $376K.
  • Shattuck Labs made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #7770 holding.
  • Citadel Advisors first reported a position in Shattuck Labs in Q3 2021 and has held it in 14 quarters since.
  • Citadel Advisors's Shattuck Labs position peaked at $1.52M in Q4 2021.
  • 84 funds tracked by Wall St. Rank held Shattuck Labs as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.